Inside Information / Ad-hoc Announcements 2017

Here you find Inside Information according to Article 17 MAR / Ad-hoc messages of year 2017.

To view the PDF documents you will need the Acrobat Reader. Please click here to download the free Adobe Acrobat Reader software.

June 30, 2017
09:18 a.m. CEST
Bayer expects negative earnings impact from its Brazilian Crop Science businessDownload PDF collect (65 KB)
February 08, 2017
04:35 p.m. CET
Bayer: Phase III COMPASS study with Bayer’s Rivaroxaban in Patients with Coronary or Peripheral Artery Disease Shows Overwhelming Efficacy and Meets Primary Endpoint EarlyDownload PDF collect (66 KB)

Investor News issued in year 2017 can be found here.

Publications of the previous years are offered in the Archive Overview.